Rudy Mazzocchi has over 25 years of senior management and financing experience in the medical devices industry. He has served as Managing Director with Accuitive Medical Ventures and The Innovation Factory (Atlanta, GA) and CEO of Image-Guided NEUROLOGICS (Melbourne, FL), an early stage neurosurgical device company acquired by Medtronic in August 2005. He was Chairman and Interim-CEO of Triton BioSystems, a company developing a nanotechnology based approach to cancer therapy, which recently merged with Oncologics, Inc. of Berkeley, CA. He was also Founder, President and CEO of MICROVENA Corporation, an interventional medical device company now known as “eV3”, a publicly traded company in Minneapolis, MN. Mr. Mazzocchi has served as a director at several start-up medical companies including Vascular Science (acquired by St. Jude Medical), CytoGenesis (acquired by BresaGen), and Thermonix (acquired by Triton BioSystems). He is currently President and CEO of Elenza, an opthamology products company based in Raleigh, NC.
Cary Adams, JD has over 30 years healthcare law experience with Murphy, Austin, Adam, Schoenfeld LLP and Diepenbrock, Wulff, Plan and Hannigan in Sacramento. He has also lectured on healthcare law at the University of Southern California and the University of California at Davis. He is the founding president of the Sacramento Angels, a limited partner in Tenex Greenhouse Ventures and DJF Frontier Fund II, and the founding chairman of the Sacramento Area Regional Technology Alliance.
Joel Braunstein, MD, MBA, FACC is a board certified cardiologist and internist affiliated with Yale University School of Medicine and the Yale Center for Outcomes Research and Evaluation. Dr. Braunstein is co-founder and managing partner of LifeTech Development Partners, a recently formed partnership that led the series A investment round in NexGen. He is also co-founder and CEO of LifeTech Research, a life sciences investment research firm formed in 2003; co-founder and Chairman of Centegen, Inc, a therapeutics company developing novel agents against drug-resistant bacterial infections; and co-founder and board member of C2N Diagnostics, a diagnostics and therapeutic biomarkers company focused on Alzheimer’s Disease and other forms of neurodegeneration. He also currently sits on the Board of Directors of Tivorsan Pharmaceuticals and Correx, Inc.
John Kucharczyk. Dr. Kucharczyk was a member of the Board of Directors at BresaGen, Inc. (2001-03), CytoGenesis (1999-2001), Image-Guided Neurologics (1997-2005), Quasm, Inc. (1998-2005), and ITI Medical Technologies, Inc. (1993-97).
Richard Latchaw, MD has had a 30-year career in neuroradiology at the University of California at Davis, University of Miami, University of Pittsburgh, and University of Minnesota. He is the author of over 400 medical publications and several books related to diagnostic neuroradiology, interventional neuroradiology and neurosurgery. Dr. Latchaw is Past President of the American Society of Neuroradiology.
Jeffrey N. Hausfeld, M.D, M.B.A graduated from the MBA Program in the Business of Health Program at Johns Hopkins in 2005 and retired from the practice of Otolaryngology. Dr. Hausfeld represented three major pharmaceutical companies as their national spokesperson. In 2006, he completed a graduate certificate program at George Washington University in Leadership Coaching and Organizational Development. Dr. Hausfeld is currently one of the Managing Directors of FMS Financial Solutions, a national debt collection and debt acquisition firm specializing in medical debt collection. Over the past two years, he has been working to syndicate a healthcare related real estate venture where a new entity, Memory Care Communities of Illinois LLC, will construct ten Assisted Living facilities in the Midwest specializing in the care of Alzheimer’s and dementia patients. Through the contributions of Hedge Funds and private equity investors, he has raised six million dollars in commitments. He continues to strive to achieve “Centers of Excellence” through his contacts with the Alzheimer’s Association of America as well as universities specializing in geriatrics and neurosciences. In 2011, Dr. Hausfeld became Cofounder and Treasurer of the Society of Physician Entrepreneurs, a nonprofit organization whose mission is to assist healthcare providers in commercializing their innovations through networking, education and sharing their experiences.